Chemotherapy of non-Hodgkin's lymphomas-Reference-Cited by-同舟云学术

Chemotherapy of non-Hodgkin's lymphomas

Published:1991-01 Issue:1 Volume:4 Page:157-179
ISSN:0950-3536
Container-title:Baillière's Clinical Haematology
language:en
Short-container-title:Baillière's Clinical Haematology

Author:

Cavalli F.

Publisher

Elsevier BV

Subject

Hematology

Reference73 articles.

1. Treatment of diffuse aggressive non Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP);Amadori;Seminars in Oncology,1985

2. Interpretation of clinical trials in diffuse large-cell lymphoma;Armitage;Journal of Clinical Oncology,1988

3. Peripheral T-cell lymphoma;Armitage;Cancer,1989

4. Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia;Bernasconi;Annals of Oncology,1990

5. Long-term remissions in lymphoblastic lymphoma;Bertino;Journal of Clinical Oncology,1983

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial;European Journal of Haematology;2009-04-24

2. Prognostic factors in patients with aggressive non-Hodgkin’s lymphoma without complete response to first-line therapy;Advances in Therapy;2006-07

3. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin’s lymphoma;Annals of Hematology;2005-04-15

4. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens;CANCER-AM CANCER SOC;2001

5. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens;Cancer;2001